Gene Therapy Drugs That Cost Millions Have Employers and Health Plans Worried

Employers and health plans fear they could be swamped financially by a coming wave of expensive new genetic therapies for rare diseases. Regulators have recently approved two treatments that sell at many multiples of the prices of routine treatments for …

from News – Insurance Journal